Navigation Links
Genetic basis of high-risk childhood cancer points to possible new drug treatment strategy
Date:1/20/2013

(MEMPHIS, Tenn. January 20, 2013) Research led by St. Jude Children's Research Hospital scientists has identified a possible lead in treatment of two childhood leukemia subtypes known for their dramatic loss of chromosomes and poor treatment outcomes.

The findings also provide the first evidence of the genetic basis for this high-risk leukemia, which is known as hypodiploid acute lymphoblastic leukemia (ALL). Normal human cells have 46 chromosomes, half from each parent, but hypodiploid ALL is characterized by fewer than 44 chromosomes. Chromosomes are highly condensed pieces of DNA, the molecule that carries the inherited instructions for assembling and sustaining a person. The research appears in the January 20 advance online edition of the scientific journal Nature Genetics.

The study, the largest ever focused on hypodiploid ALL, confirmed that this tumor has distinct subtypes distinguished by the number of chromosomes lost and the submicroscopic genetic alterations they harbor. Researchers found evidence suggesting more than one-third of patients with a subtype known as low hypodiploid ALL have Li-Fraumeni syndrome. Families with Li-Fraumeni syndrome harbor inherited mutations in the TP53 tumor suppressor gene and have a high risk of a range of cancers. Hypodiploid ALL had not previously been recognized as a common manifestation of Li-Fraumeni syndrome.

Researchers reported that the major hypodiploid subtypes are both sensitive to a family of compounds that block the proliferation of cancer cells. The compounds include drugs already used to treat other cancers. The subtypes are low hypodiploid ALL, characterized by 32 to 39 chromosomes, and near haploid ALL, which has 24 to 31 chromosomes.

"This study is a good example of the important insights that can be gained by studying the largest possible number of patients in as much detail as possible. This approach led us to key insights about these leukemia subtypes
'/>"/>

Contact: Carrie Strehlau
media@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Your Genetic Secrets May Not Be as Safe as You Think
2. Researchers identify genetic mutation for rare cancer
3. Almost Nuts! a Wisconsin Company Innovates Healthy Snack Foods that are Not Genetically Modified
4. Kidneys Sometimes Removed Needlessly in Patients With Rare Genetic Disorder
5. Study Suggests Genetic Link Between Epilepsy, Migraine
6. U-M sibling study discovers genetic region linked to control of key blood-clotting protein
7. Scientists ID New Genetic Connection for Gout
8. New technique catalogs lymphoma-linked genetic variations
9. A genetic defect in sex cells may predispose to childhood leukemia
10. Cleveland Clinic researcher identifies 2 new genetic mutations associated with Cowden syndrome
11. Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Carson Hearing Care has launched ... health care tips to local residents on a consistent ... offer weekly articles from the audiologists at Carson Hearing ... latest advances in hearing restoration research, new tinnitus treatment ... plan to write a new post on the blog ...
(Date:8/29/2014)... new report released yesterday by the Mental Health ... mental health training and education that police personnel ... prominent issue for Canada,s police community, and today,s ... law enforcement and people with mental illnesses," says ... with an interest in the area of police ...
(Date:8/29/2014)... team of scientists from the University of Colorado School ... process to expand production of stem cells used to ... extend beyond cancer, including treatments for inborn immunodeficiency and ... published Aug. 29 in PLOS ONE , ... Medicine and Stem Cell Biology and Taiga Biotechnologies, Inc. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... Steven Reinberg ... News) -- The vast majority of American babies are ... serious illnesses, federal health officials said Thursday. More ... that prevent measles, mumps, and rubella (MMR); polio; hepatitis ... for Disease Control and Prevention. "Nationally, vaccination among ...
Breaking Medicine News(10 mins):Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Report advocates improved police training 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
... Liposuction and Body/Facial Reshaping visualizations TORONTO, May ... intelligent, life-like facial and body simulations performed ... of its latest plastic surgery visualization tool, ... LiftMagic.com, a popular online anti-aging visualization tool ...
... Development Authority, highlights New Jersey,s talented workforce and ... prosperityPARSIPPANY, N.J., May 13 Daiichi Sankyo, Inc. ... completed a major renovation and build-out of the ... facility to accommodate its growing workforce, creating sole ...
... announces that it has enrolled its 1,000th patient into ... R esponsiveness with A V erifyNow(R) Assay ... S afety). The trial is specifically designed to ... for patients who are poor responders to clopidogrel (Plavix(R)). ...
... Who: JEFFERSONS RESTAURANT VIP PREMIERE GALA, ... When: 5pm on Monday, May 18, 2009, ... Nashville,s historic Jefferson Street is known for its legendary live concerts with ... each contributing to the ambience of the rich R/B history of this ...
... High serum ferritin, being a hallmark of hereditary ... C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty ... has investigated the link between ferritin and steatosis ... southern European populations, high ferritin levels, after exclusion ...
... RWD(R) Healthcare Practice to Streamline Patient Flow and Improve ... some hospitals are struggling financially, St. Luke,s Episcopal Hospital ... efficient patient care with quality at its core. In ... is streamlining its transfer process for patients who need ...
Cached Medicine News:Health News:ModiFace Launches ReShapr.com, the World's First Free Online Plastic Surgery Visualization Tool 2Health News:Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters 2Health News:Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters 3Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:Belmont University Graduate Launches Healthy Soul Food Restaurant on Nashville's Historic Jefferson Street 2Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 2Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 3Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 4
(Date:8/29/2014)... 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products Implements ... the SAM Junctional Tourniquet.  Photo ... Medical Products announced today that it has begun ... a potential issue with a clip used to ... application of the SAM Junctional Tourniquet (SJT).  The ...
(Date:8/29/2014)... 29, 2014 Pomerantz LLP has filed a ... "Company") (NASDAQ: EDAP ) and certain of ... District Court, Southern District of New York ... of a class consisting of all persons or entities ... July 30, 2014, inclusive (the "Class Period"). This class action ...
(Date:8/29/2014)...  A Boston Scientific Corporation (NYSE: ... and preliminary long term stricture resolution of benign ... issue of the peer-reviewed journal, Gastroenterology. ... conducted in 11 countries and five continents, and ... (FCSEMS) after extended indwell (i.e., up to 12 ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... NEW YORK, Dec. 2 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... and Drug Administration (FDA) has granted Fast Track designation ... anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, ... , The Fast Track program of the FDA is ...
... BIRMINGHAM, Ala., Dec. 2 Adults are more likely to ... over, the odds of losing vision are one in three, whereas the ... odds of a woman developing breast cancer are one in nine. ... risk of injuries, depression and inability to complete daily tasks. , Vision ...
Cached Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2
... standard trial frames. They are made of optical quality ... box. There are two sets available providing a full ... is that a patient can wear the prism with ... the patient to adapt to the use of the ...
... C Dermatome - reaching a new evolutionary plateau. ... to operate in the pulse mode, or to ... entire instrument and hose assembly is autoclavable and ... 2-, 3-, or 4-inch widths. Simply select the ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Medicine Products: